BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Prognosis
11 results:

  • 1. The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.
    Song Q; Xu SX; Wu JZ; Ling L; Wang S; Shu XH; Ying DN; Pei WW; Wu YC; Sun SF; Zhang YN; Zhou SH; Shao ZY
    Front Immunol; 2023; 14():1177403. PubMed ID: 37457691
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis.
    Yang J; Jin Y; Cheng S; Wang C; Zhang N; Huang S; Zhao Y; Wang Y
    J Ovarian Res; 2021 Aug; 14(1):106. PubMed ID: 34404438
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
    Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
    Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031.
    Sarr A; Bré J; Um IH; Chan TH; Mullen P; Harrison DJ; Reynolds PA
    Sci Rep; 2019 May; 9(1):7643. PubMed ID: 31113993
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
    Merritt MA; Rice MS; Barnard ME; Hankinson SE; Matulonis UA; Poole EM; Tworoger SS
    Lancet Oncol; 2018 Aug; 19(8):1107-1116. PubMed ID: 30029888
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
    Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
    J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients.
    Reitter EM; Ay C; Kaider A; Pirker R; Zielinski C; Zlabinger G; Pabinger I
    Clin Exp Immunol; 2014 Jul; 177(1):253-60. PubMed ID: 24580121
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
    Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR
    Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
    Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
    Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Superficial lymph node metastasis from ovarian cancer--an analysis of 31 cases].
    Hou YJ
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):466-8. PubMed ID: 2076648
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.